- Datametrex AI (TSXV:DM) is considering a possible spinout of its healthcare division with a distribution of shares to existing shareholders
- The intent is to focus on its artificial intelligence (AI) businesses
- Management believes this strategic separation will empower Datametrex and a new healthcare-focused entity to maximize their respective potentials and achieve success in their specialized areas
- Datametrex AI stock (TSXV:DM) opened trading at $0.07 per share
Datametrex AI (TSXV:DM) is considering a possible spinout of its healthcare division with a distribution of shares to existing shareholders.
In a news release, the company’s leadership explained the intent is to focus on its artificial intelligence (AI) businesses. By divesting its healthcare division, Datametrex can focus on its core operations in AI, GPT and EV technologies.
Datametrex’s healthcare division includes Medi-Call Inc., Imagine Health Medical Clinics Ltd., Imagine Health Pharmacies & Research Ltd. and Imagine Health Physio Ltd.
Source: Datametrex AI Ltd.
Management believes this strategic separation will empower Datametrex and a new healthcare-focused entity to maximize their respective potentials and achieve success in their specialized areas.
An independent healthcare operation could direct its undivided attention towards delivering healthcare services and ensuring the highest standards of patient care and wellness.
CEO Marshall Gunter said in a news release that the proposed spinout marks an exciting chapter for Datametrex as the company readies to grow and expand.
“By separating our healthcare division and establishing an independent entity, we can better serve the needs of our customers and deliver enhanced value to our shareholders. We believe this strategic move will enable both entities to thrive and excel in their respective fields,” Gunter said.
Datametrex AI Ltd. is a technology-focused company with exposure to AI, machine learning, telehealth, and the electric vehicle market.
Datametrex AI Ltd. opened trading at $0.07 per share.
Join the discussion: Find out what everybody’s saying about this stock on the Datametrex AI stock forum, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.